DRG’s Epidemiology team will be presenting their poster at this year's World Cancer Congress.
DRG Poster Presentation: Global impact of Tyrosine Kinase Inhibitors on chronic myeloid leukemia epidemiology over the next ten years
The advent of tyrosine kinase inhibitors (TKIs) has transformed the prognosis of CML. Prolonged survival has already been achieved in most patients with access to these drugs, and as access improves in more resource-constrained settings, it should be expected that this improvement will become more common, thus increasing the prevalence of CML. Through this analysis we aim to understand the global impact of targeted therapy on CML prevalence over the next ten years.
Don’t miss this exciting learning opportunity! Access the full conference schedule and registration info here
To arrange a meeting at World Cancer Congress, please contact us